BEG vs. CURE
BEG (Leverage Shares 2X Long BE Daily ETF) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds. BEG is actively managed, while CURE is passively managed. Their -0.10 correlation means they have often moved in opposite directions in the past. BEG charges 0.75%/yr vs 0.94%/yr for CURE.
Performance
BEG vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BEG achieves a 202.96% return, which is significantly higher than CURE's 9.84% return.
BEG
- 1D
- 5.12%
- 1M
- -47.72%
- 6M
- 17.69%
- YTD
- 202.96%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
CURE
- 1D
- 3.57%
- 1M
- 2.13%
- 6M
- 9.12%
- YTD
- 9.84%
- 1Y
- 68.16%
- 3Y*
- 9.07%
- 5Y*
- 1.03%
- 10Y*
- 13.70%
- ALL TIME*
- 24.43%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $20.75M | $16.31M | $12.30M | |
| $9.95M | $8.81M | $9.51M |
BEG vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
BEG Leverage Shares 2X Long BE Daily ETF | 202.96% | 1.77% |
CURE Direxion Daily Healthcare Bull 3x Shares | 9.84% | -1.71% |
Correlation
The correlation between BEG and CURE is -0.10, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Dec 16, 2025 | -0.10 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BEG vs. CURE — Risk / Return Rank
BEG
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CURE
BEG vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 2X Long BE Daily ETF (BEG) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BEG | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.25 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.20 | — |
| Martin ratioReturn relative to average drawdown | — | 4.95 | — |
Loading charts...
Drawdowns
BEG vs. CURE - Drawdown Comparison
The maximum BEG drawdown since its inception was -82.08%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for BEG and CURE.
Loading charts...
Drawdown Indicators
| BEG | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.08% | -69.19% | -12.89% |
Max Drawdown (1Y)Largest decline over 1 year | — | -31.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -51.93% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -52.23% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -69.19% | — |
Current DrawdownCurrent decline from peak | -65.53% | -12.82% | -52.71% |
Average DrawdownAverage peak-to-trough decline | -24.36% | -18.16% | -6.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 13.83% | — |
Volatility
BEG vs. CURE - Volatility Comparison
Loading charts...
Volatility by Period
| BEG | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 15.39% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 35.19% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 228.19% | 46.03% | +182.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 228.19% | 44.69% | +183.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 228.19% | 49.87% | +178.32% |
BEG vs. CURE - Expense Ratio Comparison
BEG has a 0.75% expense ratio, which is lower than CURE's 0.94% expense ratio.
Dividends
BEG vs. CURE - Dividend Comparison
BEG has not paid dividends to shareholders, while CURE's dividend yield for the trailing twelve months is around 1.03%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BEG Leverage Shares 2X Long BE Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CURE Direxion Daily Healthcare Bull 3x Shares | 1.03% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
Frequently Asked Questions
BEG and CURE have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BEG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BEG is cheaper with a 0.75% expense ratio, compared with 0.94% for CURE.
CURE has the higher dividend yield at 1.03%, compared with 0.00% for BEG.
They also come from different issuers: Leverage Shares and Direxion. Their fees differ too: 0.75% for BEG and 0.94% for CURE.
Find the right allocation for BEG and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer